|
IL6ST expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.76220000000149E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.955700E-04 |
| Normal-vs-Stage2 |
1.972990E-04 |
| Normal-vs-Stage3 |
1.69819999995546E-06 |
| Normal-vs-Stage4 |
1.102580E-03 |
| Stage1-vs-Stage2 |
1.865760E-01 |
| Stage1-vs-Stage3 |
4.669700E-02 |
| Stage1-vs-Stage4 |
3.674800E-01 |
| Stage2-vs-Stage3 |
8.690400E-01 |
| Stage2-vs-Stage4 |
8.475800E-01 |
| Stage3-vs-Stage4 |
6.924000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.153590E-04 |
| Normal-vs-AfricanAmerican |
2.876000E-01 |
| Normal-vs-Asian |
7.295200E-03 |
| Caucasian-vs-AfricanAmerican |
2.972800E-01 |
| Caucasian-vs-Asian |
8.452800E-01 |
| AfricanAmerican-vs-Asian |
3.648200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6964099999961E-05 |
| Normal-vs-Female |
1.760390E-04 |
| Male-vs-Female |
1.562360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.512250E-02 |
| Normal-vs-Age(41-60Yrs) |
2.16159999999466E-05 |
| Normal-vs-Age(61-80Yrs) |
1.52305999999713E-05 |
| Normal-vs-Age(81-100Yrs) |
9.700100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.186000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.616160E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.756600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.088000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.240000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.044400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.789700E-02 |
| Classical-VS-Follicular |
1.827630E-04 |
| Classical-VS-Other |
7.521100E-03 |
| Classical-VS-Normal |
2.978000E-03 |
| Tall-VS-Follicular |
5.596400E-01 |
| Tall-VS-Other |
1.430440E-01 |
| Tall-VS-Normal |
1.768030E-04 |
| Follicular-VS-Other |
2.766200E-01 |
| Follicular-VS-Normal |
3.80000000355096E-08 |
| Other-VS-Normal |
6.573500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12259999998743E-06 |
| Normal-vs-N1 |
1.777010E-03 |
| N0-vs-N1 |
7.759600E-01 |
|
|
